Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,045,067
+$216,897 QoQ
Shares Held
8,409
+4.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#1,072
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOLDERNESS INVESTMENTS CO holds $26,485,557 across 10 Drug Manufacturers - General names. AMGN ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,463 | $5,904,229 | |
| 2 | MRK |
Merck & Co., Inc.
|
32,731 | $4,205,933 | |
| 3 | JNJ |
Johnson & Johnson
|
14,009 | $3,557,865 | |
| 4 | AMGN |
Amgen Inc
This page
|
8,409 | $3,045,067 | |
| 5 | LLY |
ELI LILLY & Co
|
1,881 | $2,256,128 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,710 | $2,115,230 | |
| 7 | PFE |
Pfizer Inc
|
76,281 | $1,836,846 | |
| 8 | NVS |
Novartis AG
|
10,410 | $1,631,455 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,045,067 | 8,409 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,828,170 | 8,038 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,548,762 | 7,787 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,197,209 | 7,786 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,126,742 | 7,617 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,380,865 | 7,642 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,987,640 | 7,626 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,158,162 | 6,698 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,896,571 | 6,070 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,587,927 | 5,585 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,557,900 | 5,409 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,447,810 | 5,387 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,186,252 | 5,343 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,252,506 | 5,181 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,290,875 | 4,915 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,110,095 | 4,925 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,198,252 | 4,925 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,246,823 | 5,156 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,095,828 | 4,871 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $973,724 | 4,579 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,099,068 | 4,509 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,046,743 | 4,207 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $929,566 | 4,043 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,306,128 | 5,139 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,203,357 | 5,102 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,038,788 | 5,124 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||